Shanghai Pharmaceuticals Holding Co (SHSE:601607) Ending Cash Position : ¥27,126 Mil (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Ending Cash Position?

Shanghai Pharmaceuticals Holding Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥27,126 Mil.

Shanghai Pharmaceuticals Holding Co's quarterly Ending Cash Position increased from Sep. 2023 (¥26,572 Mil) to Dec. 2023 (¥27,500 Mil) but then declined from Dec. 2023 (¥27,500 Mil) to Mar. 2024 (¥27,126 Mil).

Shanghai Pharmaceuticals Holding Co's annual Ending Cash Position increased from Dec. 2021 (¥20,138 Mil) to Dec. 2022 (¥24,534 Mil) and increased from Dec. 2022 (¥24,534 Mil) to Dec. 2023 (¥27,500 Mil).

Shanghai Pharmaceuticals Holding Co Ending Cash Position Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Ending Cash Position Chart

Shanghai Pharmaceuticals Holding Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

15,716.26

19,576.45

20,137.50

24,533.89

27,499.81

Shanghai Pharmaceuticals Holding Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															24,104.73	28,688.34	26,571.90	27,499.81	27,125.93

Shanghai Pharmaceuticals Holding Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Shanghai Pharmaceuticals Holding Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	24533.891	+	2965.918
	=	27,500

Shanghai Pharmaceuticals Holding Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	27499.809	+	-373.878
	=	27,126

Shanghai Pharmaceuticals Holding Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (SHSE:601607) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

SHPMY:USA SHPMF:USA 02607:Hong Kong S1R:Germany

Address

No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020

Website

https://www.sphchina.com

Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.

Executives

Ren Jian	senior management
Liu Yan Jun	senior management
Hu Feng Xiang	Director
Zuo Min	Director
Guo Jun Yu	senior management
Han Min	senior management
Lou Ding Bo	Director
Chen Xin	Supervisors
Shu Chang	senior management
Li Yong Zhong	senior management
Jiang Yuan Ying	senior management
Xu Guo Xiong	Director
Shen Bo	senior management
Ge Jian Qiu	senior management

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Headlines

No Headlines